BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29891647)

  • 1. Saxagliptin Prevents Increased Coronary Vascular Stiffness in Aortic-Banded Mini Swine.
    Fleenor BS; Ouyang A; Olver TD; Hiemstra JA; Cobb MS; Minervini G; Emter CA
    Hypertension; 2018 Aug; 72(2):466-475. PubMed ID: 29891647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic exercise training prevents coronary artery stiffening in aortic-banded miniswine: role of perivascular adipose-derived advanced glycation end products.
    Ouyang A; Olver TD; Emter CA; Fleenor BS
    J Appl Physiol (1985); 2019 Sep; 127(3):816-827. PubMed ID: 31295062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine.
    Hiemstra JA; Lee DI; Chakir K; Gutiérrez-Aguilar M; Marshall KD; Zgoda PJ; Cruz Rivera N; Dozier DG; Ferguson BS; Heublein DM; Burnett JC; Scherf C; Ivey JR; Minervini G; McDonald KS; Baines CP; Krenz M; Domeier TL; Emter CA
    J Am Heart Assoc; 2016 Apr; 5(4):e003277. PubMed ID: 27098966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotid Artery Vascular Mechanics Serve as Biomarkers of Cognitive Dysfunction in Aortic-Banded Miniature Swine That Can Be Treated With an Exercise Intervention.
    Olver TD; Klakotskaia D; Ferguson BS; Hiemstra JA; Schachtman TR; Laughlin MH; Emter CA
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic interval exercise training prevents BK
    Olver TD; Edwards JC; Ferguson BS; Hiemstra JA; Thorne PK; Hill MA; Laughlin MH; Emter CA
    J Appl Physiol (1985); 2018 Jul; 125(1):86-96. PubMed ID: 29596016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac DPP-4 inhibition by saxagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats.
    Ikeda J; Kimoto N; Kitayama T; Kunori S
    J Pharmacol Sci; 2016 Sep; 132(1):65-70. PubMed ID: 27666017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice.
    Brown SM; Smith CE; Meuth AI; Khan M; Aroor AR; Cleeton HM; Meininger GA; Sowers JR; DeMarco VG; Chandrasekar B; Nistala R; Bender SB
    Endocrinology; 2017 Oct; 158(10):3592-3604. PubMed ID: 28977602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
    Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S
    Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-intensity aerobic interval training attenuates pathological left ventricular remodeling and mitochondrial dysfunction in aortic-banded miniature swine.
    Emter CA; Baines CP
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1348-56. PubMed ID: 20817828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway.
    He L; Zhang T; Sun W; Qin Y; Wang Z; Dong W; Zhang H
    Med Oncol; 2020 Oct; 37(11):97. PubMed ID: 33001278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats.
    Sakai M; Uchii M; Myojo K; Kitayama T; Kunori S
    Eur J Pharmacol; 2015 Aug; 761():109-15. PubMed ID: 25936515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of saxagliptin on adipose tissue inflammation and vascular function in overweight and obese people: a placebo-controlled study.
    Koska J; Osredkar T; D'Souza K; Sands M; Sinha S; Zhang W; Meyer C; Reaven PD
    Diabet Med; 2019 Nov; 36(11):1399-1407. PubMed ID: 30580454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The persistent inhibitory properties of saxagliptin on renal dipeptidyl peptidase-4: Studies with HK-2 cells in vitro and normal rats in vivo.
    Uchii M; Sakai M; Hotta Y; Saeki S; Kimoto N; Hamaguchi A; Kitayama T; Kunori S
    J Pharmacol Sci; 2017 Nov; 135(3):126-130. PubMed ID: 29113790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice.
    Manrique C; Habibi J; Aroor AR; Sowers JR; Jia G; Hayden MR; Garro M; Martinez-Lemus LA; Ramirez-Perez FI; Klein T; Meininger GA; DeMarco VG
    Cardiovasc Diabetol; 2016 Jul; 15():94. PubMed ID: 27391040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase-4 inhibition prevents cell death via extrinsic and intrinsic apoptotic pathways in rat pancreas with insulin resistance.
    Nephan G; Coskun ZM; Bolkent S
    Cell Biochem Funct; 2018 Jun; 36(4):212-220. PubMed ID: 29748970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.
    Dong J; Gong Y; Liu J; Chen X; Wen X; Sun H
    Bioorg Med Chem; 2014 Feb; 22(4):1383-93. PubMed ID: 24457090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System.
    Raschi E; Poluzzi E; Koci A; Antonazzo IC; Marchesini G; De Ponti F
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):380-6. PubMed ID: 27067162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats.
    Mason RP; Jacob RF; Kubant R; Ciszewski A; Corbalan JJ; Malinski T
    J Cardiovasc Pharmacol; 2012 Nov; 60(5):467-73. PubMed ID: 22932707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study.
    Ambardekar AV; Hunter KS; Babu AN; Tuder RM; Dodson RB; Lindenfeld J
    Circ Heart Fail; 2015 Sep; 8(5):944-52. PubMed ID: 26136459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.